The Corporate vision is "Innovations for a Better Life". With a focused aim, MBC exploits its expertise to develop new drugs/technologies for liver diseases and cancers of Asian significance, as well as for nucleic acid testing of HLA, HBV/HCV/HIV and other pathogens. Bridging Taiwan's biomedical R&D niches with international collaborations, MBC strives to translate basic research into FDA approved applications through its state-of-the-art molecular and clinical competence. With a lofty goal for the society and the mankind, MBC commits to become a leader fighting against liver and cancer diseases in Asia and to contribute to a better life through innovations.